Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Endometrial Cells and PRP for Thin Endometrium
NCT05455151Phase 1Completed
- Start
- Oct 2018
- Primary completion
- Jan 2021
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, open-label trial of platelet-rich plasma and autologous endometrial cells in thin endometrium and infertility (4 arms). Primary endpoints: Change in endometrial thickness at 2 months, Doppler-assisted detection of the uterine spiral arteries at 1 month and 3 more. Started Oct 2018; status: completed.
02
Drugs
platelet-rich plasmaautologous endometrial cells
03
Conditions
thin endometriuminfertility
Beyond the preview
Go deeper on NCT05455151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05455151.